First, we analyzed the survival outcomes of over 11,000 patients from The Cancer Genome Atlas (TCGA) Pan-Cancer (PANCAN) database (https://www.cancer.gov/tcga), categorizing them based on their CD163 and SPP1 expression levels. Here, CD163 is linked to cancer.